Additionally, previous reports have demonstrated that AZGP1 suppresses the EMT or induces mesenchymal-to-epithelial trans-differentiation by blocking the TGF-β-ERK pathway in hepatocellular carcinoma and pancreatic cancer 20, 21. This evidence concerns the gene TGFB1 and pancreatic neoplasm.